4
Total investments
0
Early stage
0
Mid stage
2
Late stage
25y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2013
Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue.
www.xeltis.com
Board member
Oct 2010
At Diagenode, a Hologic company, our goal is to build epigenetics products with pride and the highest level of performance.
Overview
Diagenode, a Hologic company, is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. based in Liege, Belgium and NJ, USA. It was acquired by Hologic in March 2021.
The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.
► EPIGENETICS RESEARCH : Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available.
► MOLECULAR DIAGNOSTICS : Diagenode offers amplification and quantification methods for DNA targets of human infectious disease to meet the fast-paced growth of human disease diagnostics. We also provide guidance to diagnostics companies to develop epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and of highest quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485.
Experience · 7 entries
All (7)
Investments (4)
Board (4)
2014
C
Chabé
Managing Director
Feb 2014
2013
Board Member
Oct 2013
Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue.
www.xeltis.com
2012
O
Ophta Point Vision
Board member
Sep 2012
2010
Board member
Oct 2010
At Diagenode, a Hologic company, our goal is to build epigenetics products with pride and the highest level of performance.
Overview
Diagenode, a Hologic company, is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. based in Liege, Belgium and NJ, USA. It was acquired by Hologic in March 2021.
The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.
► EPIGENETICS RESEARCH : Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available.
► MOLECULAR DIAGNOSTICS : Diagenode offers amplification and quantification methods for DNA targets of human infectious disease to meet the fast-paced growth of human disease diagnostics. We also provide guidance to diagnostics companies to develop epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and of highest quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485.
H
HELSE
Managing Partner
Jan 2010
Show all 7 entries ↓
Investment activity
2001–2013 · 4 investments
Recent (last 2 years)Earlier